Impact of Vitamin C on Immune Response and Edema Following Near‐Infrared Photoimmunotherapy ( NIR‐ PIT )
Cancer Science · 2025
DOI: 10.1111/cas.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Hiroshi Yamamoto und 10 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. Hauptthemen laut MEDLINE: Ascorbic Acid, Immunotherapy, Edema, Phototherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Nihon University, CCR NIH HHS, Center for Cancer Research.
Abstract (Originalsprache)
Near‐infrared photoimmunotherapy (NIR‐PIT) is a recently approved cancer therapy utilizing an antibody conjugated to IR700 dye which is injected and then followed with focal NIR light. NIR‐PIT is ideal for focal therapy of cancer because of its cell specificity and minimal invasiveness compared to surgical resection. Most treatment‐emergent adverse events are low grade and include edema, fatigue, and pain. However, edema in specific anatomic locations could lead to significant complications, such as airway obstruction, and thus, it is desirable to reduce edema if possible. Edema and the resulting pain are likely precipitated by reactive oxygen species generated primarily from the interaction of laser light with unbound antibody–photoabsorber conjugate. These reactive species can be neutralized by reducing agents, such as vitamin C, a potent reducing agent and proton donor. Based on its photochemical mechanisms, we hypothesized that pretreating patients with L‐sodium ascorbate (L‐NaAA) will reduce NIR‐PIT‐induced edema. Here, we evaluated the effect of L‐NaAA concentration on edema as well as its effect on the immune responses after NIR‐PIT. L‐NaAA demonstrated concentration‐dependent inhibition of edema after NIR‐PIT without compromising the efficacy of NIR‐PIT. Furthermore, L‐NaAA did not impede the anticancer immune activation elicited by NIR‐PIT, nor did it affect the efficacy of Treg‐targeted NIR‐PIT. NIR‐PIT groups, both with and without L‐NaAA, significantly inhibited tumor growth and resulted in markedly prolonged survival compared to the control group, but those with L‐NaAA had reduced edema. Thus, L‐NaAA may serve as a useful adjunct to NIR‐PIT, enhancing its safety profile without detracting from its therapeutic efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
ORCID-Profile: Aki Furusawa, Hiroshi Fukushima, Hisataka Kobayashi
Förderung
- Nihon University
- CCR NIH HHS
- Center for Cancer Research
Zitieren
APA
Yamamoto, H., Furusawa, A., Fukushima, H., Takao, S., Suzuki, M., Kano, M., Kano, M., Okuyama, S., Kitamura, K., Choyke, P. L., & Kobayashi, H. (2025). Impact of Vitamin C on Immune Response and Edema Following Near‐Infrared Photoimmunotherapy ( NIR‐ PIT ). Cancer Science. https://doi.org/10.1111/cas.70070
Vancouver
Yamamoto H, Furusawa A, Fukushima H, Takao S, Suzuki M, Kano M, et al. Impact of Vitamin C on Immune Response and Edema Following Near‐Infrared Photoimmunotherapy ( NIR‐ PIT ). Cancer Science. 2025. doi:10.1111/cas.70070
BibTeX
@article{Yamamoto2025,
author = {Yamamoto, Hiroshi and Furusawa, Aki and Fukushima, Hiroshi and Takao, Seiichiro and Suzuki, Motofumi and Kano, Makoto and Kano, Miyu and Okuyama, Shuhei and Kitamura, Ko and Choyke, Peter L and Kobayashi, Hisataka},
title = {Impact of Vitamin C on Immune Response and Edema Following Near‐Infrared Photoimmunotherapy ( NIR‐ PIT )},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70070}
}
EUVIMED